TI Q2 FY27 Results Analysis: PAT Plunges 58%, Margin Misses Guidance

Cofacto Research Published October 30, 2026 4 min read
Negative

TI's Q2 FY27 numbers came in soft, with revenue of Rs. 1,035.30 Cr (+172.72% YoY) and PAT growth of -57.72% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quick Details
Results dateOctober 30, 2026
Revenue (Q2)Rs. 1,035.30 Cr (+172.72% YoY)
PAT (Q2)Rs. 22.27 Cr (-57.72% YoY)
EBITDA margin14.29% (-157 bps YoY)
EPS (Q2)Rs. 0.90 (-66.79% YoY)

Quarter Snapshot

Q2 FY27 net revenue of Rs.1,035.30 Cr was flat sequentially and EBITDA margin of 14.29% missed management's guidance of being similar to Q1's 16.15%, as COGS jumped 1,195 bps as a share of net revenue. PAT fell 57.72% YoY, H1 operating cash flow was negative at Rs.(4.06) Cr, and net debt rose Rs.149.28 Cr, moving away from the ~Rs.1,700 Cr March-2027 target. The investment case now hinges on a management-guided Q3/Q4 margin recovery and a Rs.383.80 Cr H2 net-debt reduction, both of which look stretched after H1 execution.

Q2 FY27 Expectations vs Results

DriverExpected before resultsWhat happenedVerdict
Revenue in-line to ahead, share/mix-led not market-led"Q2's read hinges on whether IB sustained 2 mn+ monthly cases"Net revenue Rs.1,035.30 Cr, +172.72% YoY but (1.03)% QoQ vs Rs.1,046.03 Cr — in-line; flat sequentiallyPlayed out
Margins flat-to-compressing vs Q1's 14.5% subsidy-adjusted base"margins likely flat-to-compressing QoQ"14.13% subsidy-adjusted (14.29% reported) — compressedPlayed out
Glass inflation bleeding into early-Q2 COGS, soda-ash relief late"pass-through lags mean Q1's glass inflation likely still bleeds into early Q2 COGS"COGS 64.20% of net revenue vs 52.25% in Q1 (no filing attribution) — directionPlayed out
Net debt path toward ~Rs.1,700 Cr; Telangana dues overhang"Rs.3,900 Cr of unpaid Telangana dues… receivable days a live drag"Net debt Rs.2,083.80 Cr, +Rs.149.28 Cr vs Mar-26; receivables +22.29% — drifted away from targetPartially
Exceptionals shrinking from Rs.30 Cr"exceptional items shrinking"Rs.10.95 CrPlayed out
Telangana price hike "not confirmed"no notification found in the windowNo price action visible in the filingNot observable in the filing
FTA benefit guided from Q3 FY27 — no Q2 P&L help"no Q2 P&L help"Filing silent on FTA impact — consistentNot observable in the filing

Read our full results preview.

Management Guidance vs Delivery

What management saidWhereWhat happenedVerdict
Q2 FY27 EBITDA margin "similar" to Q1 FY27 (impacted by incremental A&SP reinvestment), with significant Q3/Q4 uptickQ1 FY27 earnings call (July 2026)14.29% reported / 14.13% subsidy-adjusted vs Q1's 16.15% / 14.48% — below the Q1 print on both basesMissed
Net debt ~Rs.1,700 Cr by March 2027 (from Rs.2,100 Cr at Jun-26, management's figure)Q4 FY26 earnings call and FY26 annual reportRs.2,083.80 Cr at Sep-26; +Rs.149.28 Cr vs Mar-26 — needs ~Rs.384 Cr H2 reduction after an H1 increaseStretch
Exceptional costs to "reduce significantly over the remainder of FY27"Q1 FY27 earnings callRs.10.95 Cr in Q2 vs Rs.30.12 Cr in Q1On Track
FY29 EBITDA margin 16–18%FY26 annual reportQ2 at 14.29%Too Early
Integration of IB "substantially completed", focus shifting to growth (CMD, Q1 FY27 close)IB integration/transition exceptional costs fell 64% QoQ to Rs.10.95 CrConfirmed
"Remain confident of improving upon the 15.5% baseline EBITDA margin achieved in Q4 FY26" (CMD, Q1 FY27)Q2 margin 14.29% (14.13% adj) sits below that base; management's own plan puts the recovery in Q3/Q4Too Early
"Steadily deleverage the balance sheet" (CMD)Net debt +Rs.149.28 Cr in H1 vs Mar-26, away from the Rs.1,700 Cr Mar-27 target — for H1Contradicted
Input-cost pressure "short-lived" (Q1 FY27 call)COGS at 64.20% of net revenue vs 52.25% in Q1; filing offers no attribution — not contradicted in the filingToo Early

Key Investment Insights

Key Positives

  • Net revenue grew 172.72% YoY to Rs.1,035.30 Cr, entirely acquisition-led (Imperial Blue consolidated from December 1, 2025)
  • Exceptional integration/transition costs fell 64% QoQ to Rs.10.95 Cr from Rs.30.12 Cr, on track with management's guidance to reduce significantly
  • Gross borrowings reduced Rs.93.15 Cr in H1 to Rs.2,201.77 Cr
  • EBITDA grew 104.88% YoY in H1 to Rs.316.90 Cr
  • Strategic investments: BTD (tequila) tranche 1 completed at Rs.6.00 Cr for ~12.5% fully diluted; RTCP (Bartisans) stake raised to 41.45%

Risk Factors

  • EBITDA margin fell to 14.29% (14.13% subsidy-adjusted), missing management's guidance of being 'similar' to Q1's 16.15% reported / 14.48% adjusted
  • COGS jumped from 52.25% to 64.20% of net revenue (+1,195 bps QoQ) with no attribution in the filing
  • H1 operating cash flow was negative at Rs.(4.06) Cr vs +Rs.69.65 Cr a year ago; receivables rose 22.29% and inventories 32.04%
  • Net debt rose Rs.149.28 Cr in H1 to Rs.2,083.80 Cr, requiring a Rs.383.80 Cr H2 reduction to reach the ~Rs.1,700 Cr March-2027 target
  • Interest coverage (EBITDA/finance cost) fell to 2.14x from 28.67x a year ago after the Rs.3,442 Cr Imperial Blue acquisition
  • Qualified audit conclusion on lack of Ind AS 36 impairment assessment of one ENA plant remains unresolved
Share on X · LinkedIn · WhatsApp

Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.

Powered by Cofacto — AI research platform for Indian stocks, every claim cited from primary filings

Login Now